2 Great Investments You Don’t Want to Miss

Risk-averse investors shouldn’t miss out on two great dividend stocks that could deliver rock-steady cash inflows in 2022.

| More on:

The stock market usually turns bearish after an extended bull run. On November 26, 2021, the TSX’s skid was a sign of weakness, but it doesn’t mean it entered bear market territory, and it has to drop at least 20% to formalize its entry. While the index is still up 18.36% year to date, there’s no telling if the recent selloff is a prelude to a sharper correction.

Meanwhile, investors are better off staying on instead of sitting out the market. There are investment opportunities you don’t want to miss. You can seek safety in a consumer-defensive stock, like North West (TSX:NWC), or take a position in Medical Facilities (TSX:DR) for superior returns in 2022.    

Retail monopoly

North West is a no-frills, straight-up choice for risk-averse investors. This $1.66 billion food retailer and general merchandise provider is one of Canada’s oldest companies. The markets in extreme geographies or remote communities that very few dare to serve have been the focus for decades. Thus, it has benefited from a monopoly up to the present.

Performance-wise, NWC investors are up 9.99% year to date. At $34.59 per share, the consumer staples stock pays a hefty 4.33% dividend. In the last 31.2 years, the total return is 60,049.09% (22.76% CAGR). In Q2 2021 (quarter ended July 31, 2021), the company increased its quarterly dividend by 2.8%.

After the first half of this year, net earnings grew 10.5% to $82.68 million. Regarding the performance in the second quarter, NWC president and CEO Dan McConnell said, “This has been another strong quarter particularly considering the extraordinary pandemic-related same-store sales and earnings increases in 2020.”

McConnell added that NWC is doing its part by adapting to the evolving business conditions to keep market share gains captured in 2020. The challenges are ongoing given the lowest vaccination rates and significant increases in COVID cases in the markets it serves.

For would-be investors, take note of the seasonal pattern of the business. Historically, sales are lowest in the first quarter and highest in the fourth quarter due to the holiday season. Moreover, e-commerce poses no significant threat to NWC. The stock price may not appreciate that much, but the dividends should be consistent and rock steady.

Rapid return of demand

Medical Facilities owns a portfolio of highly rated, high-quality surgical facilities in the United States. The COVID-19 pandemic disrupted elective surgical services in the country last year. However, the demand should return rapidly when the economy fully reopens or stabilizes.

In Q3 2021 (quarter ended September 30, 2021), facility service revenue and net income from operations declined 0.1% and 5.8% versus Q3 2020. Robert O. Horrar, president and CEO of Medical Facilities, said, “While our case volumes have not fully returned to pre-pandemic levels, we are pleased with our solid financial results over the first nine months of 2021.”  

Because of the strong cash flow performance and improving financial flexibility, management increased the quarterly dividend by 15%. According to Horrar, the increase is consistent with the company’s objective of paying a competitive and sustainable dividend. DR’s share price is $8.12, while the dividend yield is 4% if you invest today.

Valuable additions

Buy North West and Medical Facilities shares if you need to fortify your dividend stock portfolio. Both companies could deliver steady income streams in 2022.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends MEDICAL FACILITIES CORP. The Motley Fool recommends THE NORTH WEST COMPANY INC.

More on Dividend Stocks

Paper Canadian currency of various denominations
Dividend Stocks

6% Dividend Yield? Buy This Top-Notch Dividend Stock in Bulk!

This top-notch dividend stock offers a high and sustainable yield of about 6%, enabling you to generate resilient passive income.

Read more »

data analyze research
Dividend Stocks

2 High-Dividend TSX Stocks to Buy for Increasing Payouts

For big dividends with increasing payouts, look more closely at TD and CNQ today!

Read more »

Investor wonders if it's safe to buy stocks now
Dividend Stocks

Better Dividend Stock: TD vs. BCE

TSX dividend stocks such as TD and BCE offer shareholders a tasty dividend yield. But which blue-chip stock is a…

Read more »

Make a choice, path to success, sign
Dividend Stocks

Magna International: Buy, Sell, or Hold in 2025?

Magna International stock: A 5.5% dividend yield and a cheap 8.1 forward P/E – Can the automotive sector stock outrun…

Read more »

Senior uses a laptop computer
Dividend Stocks

Claiming a Home Office on Your 2024 Tax Return? Read This First

You may not be able to claim the home office tax credit, but you can claim the dividend tax credit…

Read more »

rail train
Dividend Stocks

Best Stock to Buy Right Now: CN Rail vs CP Rail?

Both these railway stocks have a strong future outlook, but which offers more value, and which more growth?

Read more »

Concept of multiple streams of income
Dividend Stocks

Here’s How Many Shares of Scotiabank You Should Own to Get $500 in Monthly Dividends

Scotiabank is a good income stock and it is reasonably valued today.

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

What to Know About Canadian National Railway Stock for 2025

CNR stock has long been a strong investment, but will that continue for 2025 with tariffs threatening growth?

Read more »